Medicine composition for preventing hyperosteogeny and preparation process thereof

Abstract

The invention discloses a medicine composition for preventing hyperosteogeny. The medicine composition comprises the following components in percentage by weight: 150-250% of rhizoma atractylodis, 12-15% of papaw, 12-15% of rhizoma ligustici wallichii, 6-8% of hemartine, 12-15% of mastic, 12-15% of myrrh, 12-15% of catechu, 12-15% of safflower and 10-30% of dragon's blood. The invention also discloses a process for preparing the medicine composition. The medicine composition prepared by the rhizoma atractylodis, papaw, rhizoma ligustici wallichii, hemartine, mastic, myrrh, catechu, safflower and dragon's blood can be prepared into paste, thermal applying medicines or water medicines, is convenient to use, is suitable for various hyperosteogeny, lumbar intervertebral disc protrusion and expansion, anemofrigid-damp arthralgia and the like, and has obvious functions on improving microcirculation, promoting osteoplast to grow, absorbing prolapsed nucleus pulposus, restoring fiber ring damage, softening interveterbral disc to reset, and the like. The invention has obvious treating functions on hyperosteogeny and lumbar intervertebral disc protrusion, and can eliminate symptoms in shorttime, enable the atrophic muscle to restore, and enable the proliferative bone digestion absorption to be restored as original.

Description

technical field [0001] The invention relates to a pharmaceutical composition, especially a pharmaceutical composition for preventing and treating hyperosteogeny. Background technique [0002] Bone hyperplasia is a normal physiological phenomenon of the human body. As we age, articular cartilage gradually degenerates and the cells become less elastic. Bones and joints are worn out unconsciously, especially the damaged articular cartilage of the neck, waist, knee joints and heels that are more active. It is difficult to repair without blood supply and nutrition. At this time, around the articular cartilage, the blood circulation is relatively strong, and there will be compensatory cartilage growth. Over time, the growing cartilage will calcify, which is hyperosteogeny, also called bone spurs. Bone spurs are generally asymptomatic and do not require treatment. But once symptoms appear, it will be transformed into a pathological state, and in severe cases, it can cause defor...

AI Technical Summary

Problems solved by technology

[0012] 3. It can also cause spinal canal stenosis, leading to waist pain, intermittent claudication, waist flexion but not extension, difficulty in walking, etc.

So far, there is no drug available to cure hyperosteogeny in China